Skip to main content

Table 1 Etiology, current treatments, and role of vasculature in the main pathologies affecting bone

From: Engineering in-vitro stem cell-based vascularized bone models for drug screening and predictive toxicology

 

Etiology/risk factors

Current treatments

Role of vasculature

Osteoporosis, loss of bone density

Altered balance of bone remodeling: greater bone removal by osteoclasts and then production by osteoblasts [18]

Administration of bisphosphonates, which shorten osteoclast life span and inhibit bone resorption [19]

Possible link between decreased production of vasodilator molecules by endothelial cells and increased bone loss [20]

Osteoarthritis, progressive degeneration of cartilage and bone

Traumatic, congenital, postoperative, metabolic, endocrine; age, joint overuse, obesity are common risk factors [274]

Symptomatic treatments through physiotherapy, orthopedic aids and orthoses, pharmacotherapy, total joint replacement [275]

Increased vascularization and neoangiogenesis in the joint; increase in VEGF level in osteoarthritic chondrocytes [43]

Osteomyelitis, infection within bone

Infection by Staphylococcus aureus, but also by other Gram-negative cocci and Gram-positive bacilli [45]

Parenteral course of broad-spectrum antibiotics and surgical debridement[46]

Poor vascularity can cause both development of the infection and resistance to antibiotics [46]

Osteonecrosis, death of bone cells, arthritis, and destruction of bone

Inadequate vascular supply to the bone; long-term steroid treatment, alcohol abuse, joint injury, arthritis, cancer are common risk factors [52]

Nonsteroidal anti-inflammatory drugs to reduce pain and inflammation; bone surgery, grafting, and joint replacement [276]

Compromised subchondral microcirculation, vascular interruption, intravascular occlusion, and extravascular compression [277]

Fractures, loss of bone contiguity

Mainly trauma; osteoporosis, low mineral density, age, tumors are common risk factors [278,279,280]

Fracture reduction and immobilization; bone autograft, allograft, or synthetic materials [59]

Vascular supply is critical for fracture healing; VEGF treatment can enhance fracture repair [57]

Osteosarcoma, bone malignancy

Occurring mostly in the medullary cavity of long bones: environmental factors, chromosomal abnormalities, p53 mutation are common risk factors [72]

Depending on the stage, chemotherapy, radiation therapy, surgery (amputation, grafting, local excision) [281]

Vasculature is critical for tumor survival, osteosarcoma generally involves downregulation of anti-angiogenic factors [73, 74]

  1. VEGF vascular endothelial growth factor